... that there has not been more dot-connecting by institutions and larger investors between Healios and ATHX thus far to move this stock higher. Volume in ATHX has been lower than average for a large number of recent trading sessions, despite the fact that the Japan strategy and Healios investment is public knowledge.
A few thoughts here:
1. We're assuming on this board that Healios' movement is due to ATHX. Might it not be?
2. ATHX still is a micro-cap and is flying below many institutions' radar.
3. Once burned, twice burned, many-times burned investors in bio/stem cell are still wary?
One would have thought the Stanford results would have sent some strapping young research analysts digging in the NASDAQ trenches, but not yet...
Excellent analysis and spot on. I agree that the shorts really want to take this down to get out at a decent level - today's hard drops were all the evidence I needed of that. If we build from here the chart will continue to look very good.
Not surprised at the sharp pullback here, being up over 100% since January -- the spike to $2.90 was just too much, too fast. This little settling out period sets up up nicely to make a strong run at taking out the next key resistance level, which breaks 5 and 10 year downtrend lines of declining tops as I have noted previously.
IBB up 4% through midday today provides us a nice backdrop to start moving up again. Long and strong.